Teva, Allergan Get FTC Approval for Generics Purchase


Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC's generics business, conditioned upon Teva's divestiture of 75 drugs to rivals. The FTC said the order will preserve competition in markets where Teva and Allergan currently compete or would have likely competed if not for the merger.



from Biotech News